![COSCIENS Biopharma Inc](/common/images/company/N_CSCI.png)
Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended the quarter with US$27.8...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.085 | 1.36765888978 | 6.215 | 6.7738 | 5.47 | 4156 | 6.22032607 | CS |
4 | 0.085 | 1.36765888978 | 6.215 | 6.7738 | 5.47 | 4156 | 6.22032607 | CS |
12 | 0.085 | 1.36765888978 | 6.215 | 6.7738 | 5.47 | 4156 | 6.22032607 | CS |
26 | 0.085 | 1.36765888978 | 6.215 | 6.7738 | 5.47 | 4156 | 6.22032607 | CS |
52 | 0.085 | 1.36765888978 | 6.215 | 6.7738 | 5.47 | 4156 | 6.22032607 | CS |
156 | 0.085 | 1.36765888978 | 6.215 | 6.7738 | 5.47 | 4156 | 6.22032607 | CS |
260 | 0.085 | 1.36765888978 | 6.215 | 6.7738 | 5.47 | 4156 | 6.22032607 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約